- Cementos Argos reported an EBITDA of COP234.58 billion in Q2 2025, showing a 12% decrease from the previous year.
- The company’s revenue for the same period was COP1.28 trillion, a decline of 4.5% from the previous year, falling short of the estimated COP1.4 trillion.
- The EBITDA margin stood at 18.3% in the second quarter of 2025.
- Net income saw a significant increase, reaching COP170 billion, which is 75% higher than the previous year.
- Analysts issued 6 buy ratings, 5 hold ratings, and 1 sell rating for Cementos Argos.
A look at Cementos Argos SA Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 3 | |
| Dividend | 3 | |
| Growth | 2 | |
| Resilience | 4 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 3.4 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Investors looking at Cementos Argos SA can find positive signs in the company’s long-term outlook, based on the Smartkarma Smart Scores. With a strong momentum score of 5, Cementos Argos SA seems to be gaining traction in the market and showing promising growth potential. Additionally, the company’s resilience score of 4 indicates its ability to weather economic uncertainties, providing investors with a sense of stability.
While the growth score of 2 suggests some room for improvement, Cementos Argos SA scores moderately in both value and dividend factors, with scores of 3. Overall, the company appears to be on a favorable trajectory with a solid foundation, making it a potential option for investors seeking a mix of growth and stability in the cement and concrete industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
